Abstract
THERE has been considerable recent interest in endogenous peptides as possible analgesic agents since the isolation of a pentapeptide with opiate-like activity (methionine-enkephalin) from porcine brain1. Of particular interest is β-endorphin, isolated from camel pituitary glands2, and now synthesised3. We report here the inhibitory effect in vitro of β-endorphin on striatal dopamine release from the central nervous system (CNS).
| Original language | English (US) |
|---|---|
| Pages (from-to) | 567-568 |
| Number of pages | 2 |
| Journal | Nature |
| Volume | 264 |
| Issue number | 5586 |
| DOIs | |
| State | Published - 1976 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'β-endorphin in vitro inhibition of striatal dopamine release'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS